Management of CPAP‑Related Ear Symptoms

Clinical Presentation

Ear pain (otalgia) is a recognized adverse effect of CPAP therapy, occurring when positive airway pressure is transmitted through the Eustachian tube into the middle ear. The 2014 Otolaryngology–Head and Neck Surgery study reported this symptom in CPAP users and described associated tympanic membrane displacement. 1

The American Academy of Sleep Medicine (AASM) recommends using nasal or intranasal masks rather than oronasal/oral interfaces for routine PAP therapy, because nasal masks produce fewer ear‑related side effects and improve adherence. This is a guideline recommendation based on 2019 AASM evidence. 2
Adding heated humidification to the CPAP device significantly reduces PAP‑related side effects such as sinus pain and headache, which can indirectly lessen overall discomfort and improve tolerance of therapy. Evidence from the 2019 AASM guideline supports routine humidification. 2

Switching from fixed‑pressure CPAP to auto‑adjusting PAP (APAP) may lower the average nightly pressure exposure while still providing therapeutic control of obstructive sleep apnea. Supported by the 2019 AASM guideline. 2
Clinicians should avoid unnecessary pressure escalation and aim to use the minimum effective pressure required to control sleep apnea, thereby reducing middle‑ear pressure elevation. This recommendation is drawn from the 2019 AASM guideline. 5
Utilizing the device’s ramp feature to gradually increase pressure at sleep onset helps patients accommodate pressure changes and may lessen ear‑popping sensations. Based on the 2019 AASM guideline. 4
A short “CPAP holiday” of 1–2 nights can be considered for patients with severe ear discomfort, provided that overall apnea control is not compromised. Evidence from the 2019 AASM guideline. 5

Mild‑to‑moderate ear pain should be managed with acetaminophen or non‑steroidal anti‑inflammatory drugs (NSAIDs); severe pain may require a brief course of opioid analgesics. The 2014 Otolaryngology–Head and Neck Surgery article outlines this analgesic strategy. 1

Refer patients to otolaryngology if ear symptoms persist despite the above interventions. The 2019 AASM guideline advises specialist referral in refractory cases. 4
Referral is also indicated when a tympanic membrane perforation is identified in a CPAP user. Documented in the 2014 Otolaryngology–Head and Neck Surgery study. 1

Do not discontinue CPAP therapy solely because of ear discomfort; the 2019 AASM guidelines emphasize that the cardiovascular and quality‑of‑life benefits of treating obstructive sleep apnea outweigh the potential harms of transient ear symptoms. [2][5]
The benefits of PAP therapy for symptomatic obstructive sleep apnea are considered strong (Class I recommendation) and outweigh the risk of ear‑related side effects. Derived from the 2019 AASM guideline. 5